Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Artrya Limited ( (AU:AYA) ) has provided an announcement.
Artrya Limited has notified the market of changes to its issued capital via an Appendix 3H filing, confirming the lapse of a tranche of performance rights. The update reflects routine capital management activity, with no additional context provided on operational performance or strategic direction.
The company reported that 613,334 performance rights, designated under the ASX code AYAAAF, have ceased due to the relevant conditions not being met or becoming incapable of satisfaction as of 20 February 2026. The cessation slightly reduces potential future dilution for existing shareholders but does not involve any cash movement or immediate impact on the company’s balance sheet.
The most recent analyst rating on (AU:AYA) stock is a Hold with a A$3.00 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited is an Australia-listed company on the ASX under the code AYA. The filing does not specify its industry, products or services, and the disclosure is limited to changes in its issued capital structure rather than operational details.
Average Trading Volume: 637,716
Technical Sentiment Signal: Buy
Current Market Cap: A$510.6M
For an in-depth examination of AYA stock, go to TipRanks’ Overview page.